BioLife Solutions (NASDAQ: BLFS) reported Q3 EPS of ($0.08), $0.01 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $2.1 million versus the consensus estimate of $2.2 million.

For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.